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Cell-mediated immunity is considered to be normal in Darier’s Disease (DD), an inherited skin disorder complicated by skin
infections.Todate,therearenoinvestigationsonthelocalinﬂammatoryinﬁltrateinDDskinlesions.Inthisimmunohistochemical
study we characterized and quantiﬁed it, making comparisons with two other inﬂammatory skin disorders, that is, pemphigus
vulgaris (PV) and lichen ruber planus (LRP), and with the normal skin (NSk). We found a signiﬁcant (P<. 05) decrease of CD1a+
Langerhans cells (LCs) in DD, compared to PV, LRP, and NSk, and of CD123+ plasmacytoid dendritic cells (pDCs), compared to
PV and LRP. We hypothesize that the genetic damage of keratinocytes might result in a loss of some subsets of dendritic cells and,
consequently, in an impaired local immune response, which might worsen the infections that inevitably occur in this disease.
1.Introduction
Darier’sdisease(DD)isaninfrequentautosomaldominantly
inherited skin disorder caused by mutations in the ATP2A2
gene, which encodes a calcium pump highly expressed in
epidermal keratinocytes [1]. DD is histologically charac-
terized by dyskeratosis and acantholysis, due to an altered
keratinization and a loss of adhesion between epidermal
keratinocytes. This leads to the development of keratotic
papular lesions and plaques in the seborrheic areas of the
head, neck, and trunk; hypertrophic and bullous lesions, as
well as mucosal involvement are more rare clinical man-
ifestations of the disease. Disﬁguring, malodorous lesions
coveringmostofthebodymayalsooccurandfatalcaseshave
been reported [2]. The disease runs a chronic course; topical
(emollients,corticosteroids,retinoids,5-ﬂuorouracil),physi-
cal(excision,electrodessication,dermabrasion,ablativelaser,
photodynamic therapy), as well systemic (oral antibiotics,
retinoids) therapies are among the treatment options, which,
however, are often unsuccessful; some relief may be obtained
with systemic retinoids.
The cell-mediated immunity of DD patients was usually
found to be normal [3]. There is, however, a predisposition
to bacterial, fungal and viral infections, and defects in cell-
mediated immunity have been described, although in a
few reports [3]. It is generally believed that infections in
DD occur due to the compromised skin integrity, leading
to skin denudation and superimposed infections [3]. To
our knowledge, there are no studies that characterized
cells involved in local cutaneous immune response in DD
patients.
We herein performed an immunohistochemical analysis
and quantiﬁed the inﬂammatory cell inﬁltrate in skin
biopsies of DD patients, aiming at investigating a possible2 Mediators of Inﬂammation
pathogenic involvement of the local immune response in the
disease. For comparison, lesional skin of patients aﬀected by
pemphigus vulgaris (PV), as well as cutaneous lichen ruber
planus (LRP) was also examined.
2.SubjectsandMethods
We analyzed 16 skin biopsies of patients with Darier’s
disease (DD), ranging in age from 25 to 50 years (females
outnumbered males from 9 to 7). Nine patients had multiple
aﬀected relatives, while 7 individuals represented sporadic
cases. Six patients were at the ﬁrst DD attack, while 10
presented multiple attacks. Skin biopsies were performed
in recently-appeared, uncomplicated lesions, on grouped
keratotic papules of the abdomen and trunk. There was not
any personal nor family history of autoimmune disease.
For comparison, 14 patients with pemphigus vulgaris
(PV), ageing 30–55 years, and 10 with lichen ruber planus
(LRP), ageing 32–51 years, were also included in the
study. The diagnosis was previously established by clinical
and histopathological examination, and, in PV group, also
by immunoﬂuorescence studies. As negative control, we
examined normal skin (NSk) excised from the abdomen
of 12 healthy subjects who underwent aesthetic surgery.
Informed consent was obtained from all patients, and the
study, performed according to local ethical guidelines, was
approved by the local ethical committee.
3. Immunohistochemistry
4-μm-thick sections, cut from formalin-ﬁxed, paraﬃn-
embedded skin biopsies, were investigated immunohisto-
chemically.
I na l lc a s e s ,l e u k o c y t es u b s e t sw e r ec h a r a c t e r i z e du s i n g
a panel of antibodies, including antiCD3 (CD3 polyclonal
antibody; Neomarkers; San Diego, Ca; dilution 1:1000),
antiCD4 (CD4 polyclonal antibody, 4β12; Menarini, Flo-
rence, Italy; dilution 1:50), antiCD20 (CD20 mono-
clonal antibody, clone L26; Bio-Optica; Milan, Italy; dilu-
tion 1:150), antiCD8 (CD8 monoclonal antibody, CD8-
144B clone; Dako; Milan; dilution 1:50), antigranzyme
B (granzyme B monoclonal antibody, GZBO1 clone; Bio-
Optica; dilution 1:100), antiCD25 (CD25 polyclonal anti-
body; Bio-Optica; dilution 1:50; trypsin pretreatment)
antiFOXP3 (FOXP3 monoclonal antibody, Abcam; DBA,
Milan, Italy; dilution 1:50; microwave pretreatment),
antiCD1a (clone AB-5 010; BioOptica, Milan; dilution 1:50;
EDTA pretreatment;), antiCD68 (IgG, clone PG-M1; Dako;
dilution 1:300), and antiCD123 (6H6, eBioscience, San
Diego, CA, dilution 1:100). Antigen retrieval was obtained
either with Wcap buﬀer (pH 6, 98◦C for 40min), using the
Ultravision Detection System antiPolyvalent HRP (LabVi-
sion, Fremont, CA, U.S.A.; Bio-Optica); or with microwave
pretreatment, using the Ultravision LP Detection System
AP polymer (LabVision). Sections were then incubated with
the antibodies for 60◦C min at room temperature. For
staining development, we used either diaminobenzidine or
fuchsin (DAB; Dako), as chromogens. We also performed a
double staining with antibodies against CD25 and FOXP3
to identify the CD4+CD25+FOXP3+ subset of regulatory T
cells (Tregs), as previously described [4], and against human
CD68 and CD123 to identify the CD123+ pDCs. Treg and
pDCnucleiwerestainedinredandtheircytoplasminbrown.
Negative controls were obtained by replacing the speciﬁc
antibody with nonimmune serum immunoglobulins at the
same concentration as the primary antibody. Sections were
then counterstained with Harris haematoxylin, dehydrated
in alcohol, cleared in xylene and coverslipped.
4. Quantiﬁcationof the InﬂammatoryInﬁltrate
Inallsamples,immunohistochemicalstainingwasquantiﬁed
visually by two independent observers (C.M. and G.M.)
in at least 5 randomly chosen high power ﬁelds (HPF)
(×40 objective and ×10 eyepiece; 0.16mm2 per 1 HPF).
CD4+, CD8+, granzyme B+, CD20+, CD25+/FOXP3+,
and CD68+CD123+ cells were counted and recorded as
a percentage of the total inﬂammatory inﬁltrate. CD1a+
LCs were counted separately in the epidermis and dermis,
and given as mean number/1 HPF. Mean values + SD of
immunostained cells were statistically compared among DD,
PV, LRP and NSk by the nonparametric Kruskal-Wallis test.
The signiﬁcance level was chosen at P<. 05.
5. Results
Clinics was typical of DD (Figure 1). At histology, DD
cases showed suprabasilar acantholysis, dyskeratosis, with
overlying columns of parakeratosis, and a usually mild,
mostly lymphocytic, inﬂammatory inﬁltrate.
Blisters, due to a suprabasilar detachment, and a mild
inﬂammatory inﬁltrate, with admixed lymphocytes and
eosinophils, characterized PV lesions.
Hyperkeratosis, hypergranulosis, acanthosis and a
dense, predominantly lymphocytic, band-like, subepidermal
inﬂammatory inﬁltrate was observed in LRP samples.
In all three diseases CD3+ T lymphocytes outnumbered
CD20+ B lymphocytes (Figure 2).
In DD, CD4+ T lymphocytes constituted the large
majority of inﬂammatory cells, with a minor component
of CD8+ T lymphocytes (Figure 2); very few granzyme
B+ lymphocytes were observed. Viceversa, in PV and in
LRP, high numbers of T cells were of the CD8 phenotype,
and many granzyme B+ positive cells were observable.
Lymphocytes were rarely observed in the NSk.
In DD the epidermal, as well as the dermal CD1a+ LCs
were noticeably decreased in lesional skin when compared
with PV and LRP lesions, and NSk (Figure 3). LCs were
also smaller in size and with fewer and shorter dendrites,
when compared to NSk. In the perilesional DD skin,
when documentable in the biopsy, CD1a+ LCs reappeared,
although less numerous than those in NSk. In PV the
CD1a+ LCs appeared as isolated cells or in small clusters
in the epidermis as well as in the dermis; more numerous
than those in DD, they, however, appeared decreased when
compared to LRP and NSk and often reduced in size. InMediators of Inﬂammation 3
(a) (b)
(c)
Figure 1: Clinical manifestations of the disease, with keratotic papules ((a), (b)), erythematous plaques, and crusted lesions ((b), (c)).
(a) (b)
(c) (d)
Figure 2: The inﬂammatory inﬁltrate in Darier’s disease is mostly constituted by CD4+ T lymphocytes (a), with less numerous CD8+ T (b),
and a few CD20+ B (c) lymphocytes. Redstained, FOXP3+ nuclei of Tregs are shown in (d) Immunohistochemistry; original magniﬁcation,
×200; Scale bar = 75μm; Chromogen: fuchsin.
LRP, both epidermal and dermal CD1a+ LCs were, instead,
detectableinhighnumbers,withevident,longdendrites,and
often grouped together.
Dermal plasmacytoid dendritic cells (pDCs) were iden-
tiﬁable based on both their plasmacytoid morphology and
positivity for CD123. CD123 was also expressed by endothe-
lial cells, and therefore they served as an internal positive
control for the antiCD123 antibody (Figure 4). CD123+
pDCs were observed, at low percentages, usually single or in
groups of two, in the dermis in DD; at higher percentages,4 Mediators of Inﬂammation
(a) (b)
(c) (d)
Figure 3: Few CD1a+ LCs (an intraepidermal CD1a+ LC is indicated by the arrow), small in size, and without evident dendrites, in two
cases of Darier’s disease ((a), (b)). Normal skin showing more numerous, larger CD1a+ LCs, with long dendrites (c). An increased number
of both epidermal and dermal CD1a+ LCs in a case of lichen ruber planus (d). Immunohistochemistry. Original magniﬁcation, ×200; Scale
bar = 75μm; Chromogen: fuchsin ((a), (b)); diaminobenzidine ((c), (d)).
(a) (c)
(b)
Figure 4: A few CD123+ pDCs, as the one indicated by the thin arrow, in the inﬂammatory inﬁltrate of a Darier’s disease case (a). In
pemphigusvulgaris,CD123+pDCsaremorenumerous,usuallyfoundinthedermisand/orinsidethebulla((b),thinarrow).Alichenruber
planus skin sample showing a high number of single or grouped CD123+ pDCs in the dermal inﬂammatory inﬁltrate (c). The endothelium
of vessels ((a), (b), (c), thick arrows) is also weakly stained by the antiCD123 antibody. Immunohistochemistry; original magniﬁcation,
×200. Scale bar: A = 35μm; B, C = 45μm; Chromogen: fuchsin.Mediators of Inﬂammation 5
Table 1: Quantitative data results.
(a) Immunohistochemically-characterized inﬂammatory inﬁltrate in Darier’s disease (DD), pemphigus
vulgaris (PV), and lichen ruber planus (LRP). Mean percentages (%) +SD and range of values in brackets
are reported. P signiﬁcance is reported at the bottom.
DD PV LRP
%±SD (range) %±SD (range) %±SD (range)
CD20+ 11.1 ±4.4 (1–20) 12.6 ±3 (8–20) 13.2 ±3.8 (5–25)
CD3 90 (80–95) 90 (85–95) 85 (80–95)
CD4+ 70 ±6.2 (50–80) 47.8 ±8.6 (30–60) 49.7 ±5.8 (35–60)
CD8+ 20 ±5.4 (10–30) 40.6 ±8.9 (25–55) 40 ± 5.7 (30–50)
Granzyme B+ 3.3 ±2.7( 0 .4–0.8) 16 ±4.8 (10–30) 18.3 ±4.7 (10–30)
CD25+FOXP3+ Tregs 26 ±8.5 (8–40) 11.5 ±4.7 (1–20) 12.7 ±4.7 (8–35)
CD68+CD123+ pDC 0.6 ±0.3( 0 .2–1) 3.1 ±1.1( 0 .9–5) 9.1 ±1.7 (6–13)
(b) Mean number (N) ± SD and range of values in brackets of epidermal (e) and dermal (d) CD1a+ LCs/1
HPF, in DD, PV, LRP, and in the normal skin (NSk). P signiﬁcance is reported at the bottom.
DD PV LRP NSk
N ± SD (range) N ± SD (range) N ± SD (range) N ± SD (range)
eCD1a+ LCs 2.4 ±2 (0–7) 5.4 ±1.7 (3–10) 20.9 ±3 (15–28) 9.9 ±2.1 (7–14)
dCD1a+ LCs 3.4 ±1.1 (2–7) 4.9 ±1.6 (2–7) 18.5 ±5.5 (10–26) 5.7 ±1.4 (4–8)
P not signiﬁcant for: CD3 and CD20, among DD, PV, and LRP groups; and for CD4+, CD25+FOXP3+ Tregs,
and CD8+ in PV versus LRP.
F o ra l lt h eo t h e rc o m p a r i s o n s ,P<. 05.
LCs: Langerhans cells, Tregs: regulatory T cells, and pDCs: plasmacytoid dendritic cells.
preferentially in the dermis and inside the bullae, but also in
the epidermis in PV; in greater numbers, single and, more
often, in coalescent groups of cells, in the dermis in LRP.
CD123+ DCs were virtually absent in the NSk.
6. Statistics
Quantitative descriptive data of results and P signiﬁcance are
given in Table 1. CD3 and CD20 did not signiﬁcantly diﬀer
among the three groups. CD4+ T lymphocyte percentages
signiﬁcantly diﬀer from CD8+ percentages in each group
of lesions, CD4+ percentages being higher than CD8+ in
DD, and lower in PV and LRP. CD8+ T lymphocytes were
found at high percentages in both PV and LRP. Percentages
of CD4+, and CD8+ T lymphocytes did not statistically
diﬀer between PV and LRP. In DD, instead, CD8+ and
CD4+lymphocyteswere,respectively,signiﬁcantlylowerand
signiﬁcantly higher than those in PV and LRP. Granzyme B
lymphocyte percentages were signiﬁcantly lower in DD than
those in PV and LRP; and in PV than those in LRP.
Mean percentages of CD25+FOXP3+ Tregs were signiﬁ-
cantly higher in DD than those in PV and LRP; they did not
diﬀer between DD and LRP.
In DD, epidermal and dermal CD1a+ LC mean number,
as well as CD123+ DC percentage were signiﬁcantly lower
than those in PV, LRP and in the NSk. In PV, epidermal
and dermal Cd1a+ LC mean numbers were signiﬁcantly
lower than those in LRP. In PV epidermal CD1a+ DC mean
number was also signiﬁcantly lower than those in NSk.
CD123+ DC mean percentages were signiﬁcantly lower
in DD than those in PV and LRP; they were also signiﬁcantly
lower in PV than those in LRP.
Comparison with the NSk was limited to CD1a+ LCs,
due to the virtual absence of lymphocytes and plasmacytoid
cells in controls.
7. Discussion
A genetic basis corroborate Darier’s disease (DD), an
autosomal dominant genodermatosis, with sporadic cases
reported, in which an aberration localized to the 12q23-
24.1 region of chromosome 12 has recently been discov-
ered, leading to a defect in a keratinocyte calcium pump,
which, in turn, results in a loss of keratinocyte adhesion
and consequent acantholysis, typical of the disease [1].
Autoimmunity is, instead, the main cause of pemphigus
vulgaris (PV) and lichen ruber planus (LRP), in which
altered immune response, as well as skin inﬂammatory
cell composition, functionality and immune proﬁle have
been well documented [5–13]. DD and PV are both char-
acterized by epidermal suprabasilar acantholysis, due to
loss of adhesion between keratinocytes in the former, and
caused by autoantibodies in the latter. Despite an ascertained
predisposition to bacterial, fungal and viral infections, no
speciﬁc immunological abnormality has been discovered
in DD [3]. Infective complications are ascribed only to
superimposition of secondary infections on the denuded
skin areas [3].6 Mediators of Inﬂammation
The observation that a usually mild inﬂammatory
inﬁltrate is, however, detectable also in of recent onset,
uncomplicated DD skin lesions, prompted us to characterize
it by immunohistochemistry, in order to investigate cell
composition of the local immune response; we also made
comparison with inﬂammatory inﬁltrate of PV and LRP
skin lesions. In the latter conditions, our results are in line
with the literature [5–13]. To our knowledge, there are no
investigations, to date, that characterized the inﬂammatory
inﬁltrate in DD. In all DD skin lesions we found that it was
mostly represented by CD4+ T lymphocytes, with a minor
component of CD8+ T lymphocytes, and a negligible per-
centage of CD20+ B lymphocytes. The most striking ﬁnding
in all DD cases, in our experience, was a loss of epidermal
CD1a+ LCs in the aﬀected acantholytic and dyskeratotic
skin areas. They reappeared abruptly in the neighbouring,
apparently normal epidermis, although at lower number,
when compared to the normal skin (NSk). We also observed
low percentages of a subset of dermal dendritic cells, the so-
called plasmacytoid DCs, identiﬁable by CD123 positivity
[14]. It has been demonstrated that keratinocyte signals
induce LC proliferation [15]; keratinocytes secrete cytokines
that promote LC residence and regulate their immune
functions [16], and it has been suggested that cytokeratin
diﬀerentiation provide a microenvironment that determines
the density of Langerhans cells [17]. The profound defect of
keratinocyte diﬀerentiation in DD, could, therefore, result
in epidermal LC loss in the aﬀected epidermis. Basically,
epidermal LC functions are largely unknown [15], however,
although debated, their cooperation in generating speciﬁc
apten-induced eﬀector T cells and stimulating T-cell immu-
nity was demonstrated in some studies [18–21]. LCs were
found capable of promoting and regulating T cell–mediated
immune response [22–24], and were potent activators of
CD8+ T cells in the skin [25]. Epidermal LC reduction
or loss might contribute to a CD8-mediated eﬀector local
immune response impairment, and, consequently, to a poor
response to infective agents in DD. Furthermore, since
keratinocytes seem to function as accessory cells competent
to prime naive skin-reactive T cells [26], their defect in
DD, might directly determine an impaired CD8-mediated
eﬀector immune response.
It is known that UV irradiation exacerbates DD cuta-
neous lesions [2, 3]: this might partly be due to a direct mod-
ulation of keratinocytes by UV to produce proinﬂammatory
cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumour
necrosis factor (TNF)-A [27], leading to skin inﬂammation.
Based on the hypothesis of a haploinsuﬃciency in DD,
it was additionally hypothesized a worsening of cutaneous
lesions due to a direct downregulation of the intact allele
of the ATP2A2 gene by cytokines secreted by UV-irradiated
keratinocytes, leading to an altered intracellular distribution
of calcium, and, consequently, to a further loss of epidermal
cell adhesion, which is modulated by the cellular calcium
level [1]. On the other hand, it has been ascertained that
UV induces immunosuppression [28, 29], probably through
more than one mechanisms and targeting various cell
types, including keratinocytes, antigen presenting cells, such
as epidermal Langerhans cells (LCs), and T lymphocytes.
UV halts antigen presentation functions, and, furthermore,
expands T cell population with regulatory properties on
eﬀector immune cells [29].
Although, at least in experimental studies on mice, a
dermal subset of LC rather than epidermal LC was critical
in the UV-induced immunosuppression [30], many studies
demonstrated numerical, morphological, phenotypical and
functional abnormalities of epidermal LCs following UV
exposure [29–33]. UV seems to aﬀect LCs directly or
indirectly through suppressive cytokines [29]. In DD skin,
UV might, therefore, further on reduce LC number, that we
observed both in epidermis and dermis, contributing to a
local immunosuppression.
In our study, we also found low percentages of der-
mal pDCs, as decorated by CD123 antibody, which labels
interleukin-3 receptor alpha chain protein, that is expressed
at high levels on the surface of pDCs, allowing for their
identiﬁcation [14].
The DC system consists of two main subsets: myeloid
DCs (mDCs) and plasmacytoid DCs (pDCs) [25], and at
least ﬁve distinct DC subsets have been discovered in the
skin [34]. Epidermal CD1a+ LCs, dermal CD1a+ LCs and
CD14+ DCs are the most known mDCs in the skin, dermal
CD1a+ DCs bearing intermediate characteristics between
the ﬁrst two subsets [25]. It was hypothesized that the
humoral and the cellular arms of adaptive immunity are
preferentially regulated by CD14+ dermal DCs, and LCs,
respectively [25]. An emerging role of the plasmacytoid
subset of DCs has recently been evidenced in several skin
diseases, in which they have been found in high numbers
[35, 36]. In NSk, pDCs are low or absent [14], and they
are not altered by UVB [37]. CD123+ pDCs are capable of
producing type I interferon, and there is evidence that pDCs
are the main source of this cytokine in skin inﬂammation
[36]. CD123+ pDCs have in fact been found involved in
antiviralimmunityandinseveralautoimmunedisorders[25,
35–37]. Interferon-alpha is able to induce the production
of chemokines, which, in turn, recruite CD8+ T cells and
enhance the expression of cytotoxic mediators by NK cells
and cytotoxic lymphocytes [38, 39]. A low number of pDCs,
as we observed in DD, might result in a low production
of interferon, and interferon-inducible chemokines, leading
to an explosion of infectious agents, because of inadequate
cytotoxiclocalimmuneresponse.Wecannot,however,assess
whether the altered number of CD123+ pDCs that we
registeredmightbeascribedtothecomplexinteractionswith
other inﬂammatory cells, including CD1a+ LCs, or to other
factors.
In our experience, also in PV, we found impaired
numbers of both CD1a+ LCs and CD123+ pDCs. We, in
fact, found that in PV, CD1a+ LCs were lower than those in
NSk and LRP, and that CD123+ pDCs were lower than those
in LRP, although both DC subsets were signiﬁcantly higher
than those in DD. PV is also characterized by acantholysis,
overwhelmingly due to autoimmune mechanisms; it might
be hypothesized an additional contribute of damaged ker-
atinocytes to the decrease of some DC subsets.
We,furthermore,observedadiﬀerentpatternofCD123+
DC distribution (dermal in DD and LRP, intraepidermalMediators of Inﬂammation 7
and dermal in PV), which is supposed to have pathogenic
implications in distinct diseases [40].
In line with other studies [41], we registered signiﬁcantly
lower numbers of CD25+FOXP3+ regulatory T cells (Treg)
inPVandLRP,whereas,inDD,theirpercentageswerewithin
the range normally reported in inﬂammatory inﬁltrates.
Tregs are a phenotypically heterogeneous population of
lymphocytes which are critical for the regulatory mecha-
nismsofimmunesystem,beingresponsiblefortheinduction
and maintenance of immune tolerance. Their numbers, and,
overall, their suppressive functions were found reduced in
autoimmune as well as in allergic diseases [8, 40, 41].
FOXP3 is considered the best marker for the most
important among Treg subsets, the CD4+CD25+FOXP3+
cells, that constitute approximately 5–10% of CD4 T cells
in man [41]. The scenario of well-represented CD4+ T
inﬁltrates, with CD25+FOXP3+ within the normal range, in
f r o n to fal o wn u m b e ro fe ﬀector cells in DD skin, although
the presence of inﬂammatory cells itself does not necessary
mirror their functionality, suggest a defect of eﬀector rather
than an enhancement of regulatory cells being eﬀective in
DD. Dendritic cell numerical impairment seems the ﬁrst
Cause of a defective local immune response.
8. Conclusion
In conclusion, our present study provides direct evidence
for a numerical impairment of epidermal CD1a+ LCs and
dermal CD123+ pDCs in skin lesions of DD, which may
be pathogenetically determinant for the development of the
inﬂammatory reactions that complicate the disease. To our
knowledge, this investigation represents the ﬁrst description
of an altered composition of the cellular inﬂammatory inﬁl-
trate in this genetical disorder, suggesting that an impaired
local immune response may contribute to the progression
of the disease. The dramatic loss and/or absence of some
skin DC subsets, such those that we observed, might drive
the pathogenic events leading to DD skin complications,
suggesting novel therapeutic approaches that could open
new horizons for the treatment of this notoriously poorly
responsive disease and for a better management of patients.
Further functional studies, as well as expanding investigation
on other cells and cytokine mediators of immune response
and inﬂammation are, of course, mandatory to better
elucidate the impact of epidermal LC and dermal CD123+
DC loss in DD lesional microenviroment.
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